Page 38 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Managing cell therapy logistics during COVID-19 How does a company deal with the logistical challenges of cell sourcing, collection and delivery during a global health pandemic? Ray Hornung, head of logistics for Be The Match BioTherapies (BTMB), spoke to us about just that, and the adjustments the service provider to the cell and gene therapy (CGT) sector has implemented since February 2020. What does the company do?​ BTMB, which was founded in 2016, is an extension of bone marrow transplant facilitator, Be The Match; it looks to partner with global CGT industr...

As New Biden Regulations Move Forward, There's Fallout in Some Sectors This looks like consolidation after a big run rather than a major shift in market character. Small-cap corrective action is picking up some traction this morning, and there is some fallout in sectors like oil and pharmaceuticals as new Biden regulations are moving forward. Speculative stock picking has slowed substantially with just a couple dozen 10% movers this morning. There still is some rotational action into big caps, but it has slowed. Overall breadth is solidly negative as it approaches two losers for each ...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the

This continues to look like a very healthy market....IWM

Sickle Cell Disease Treatment Industry – Treatment, Outlook, Analysis, Research, Review To 2025